Methods | An USA prospective randomised trial | |
Participants | Number of participants: 88 Number randomised: Experimental group (BCG‐treated + surgery): 48 Control group (Control subjects + surgery): 40 Number evaluated: Experimental group: 48, age (Mean ± SD): 61 ± 9 years Control group: 37, age (Mean ± SD): 61 ± 10 years Diagnosis: Patients with potentially resectable non‐small cell carcinoma of the lung Inclusion: Patients suspected of having lung cancer were excluded if a definite diagnosis had not been established before thoracotomy. | |
Interventions |
Experimental group : Injecting BCG 10⁷ viable organisms for PPD skin test‐negative participants and 5x10⁶ for PPD‐positive participants into the tumour mass. Then underwent thoracotomy 2 to 3 weeks after intratumoural injection of BCG. Control group: All control participants underwent thoracotomy immediately following randomisation. A 12‐week course of 300 mg INH daily was given to all participants. |
|
Outcomes |
Duration of follow‐up (median ± SD): experimental group: 986 ± 412 days; control group: 1062 ± 390 days OS, Median time to recurrence |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Stratified block randomisation method."Patients were divided into 2 groups according to a table of random numbers and sealed‐envelope technique in strict numerical order of entry" |
Allocation concealment (selection bias) | Low risk | "Patients were divided into 2 groups according to a table of random numbers and sealed‐envelope technique in strict numerical order of entry" |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Open‐label design |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described |
Incomplete outcome data (attrition bias) All outcomes | Low risk | 85 randomised participants were included in analysis (96.6%) |
Selective reporting (reporting bias) | High risk | No prior protocol was available, and no pre‐specified primary outcome was reported. |
Other bias | Low risk | No obvious potential source of bias |